Story
Sandoz Shares Surge on Strong Biosimilar Sales and Reaffirmed Outlook

Sandoz (SDZ) shares surged more than 6% after the Swiss generics and biosimilars company reported stronger-than-expected second-quarter financial results and reaffirmed its full-year guidance. According to a report from Investing.com, the rally was driven by robust growth in its high-margin biosimilars segment and a significant beat on earnings per share.
Earnings Beat Powers Rally
The company announced second-quarter group net sales of $3.005 billion, edging past the analyst consensus estimate of $2.991 billion. The performance was largely fueled by the biosimilars division, which saw net sales climb 22% year-over-year to $1.022 billion.
Sandoz delivered a more substantial surprise on its bottom line. Half-year earnings per share came in at CHF 1.61, well above the consensus forecast of CHF 1.45, providing a key catalyst for the stock's upward move.
Strategic Shift and Outlook
AdSandoz management maintained its full-year 2026 forecast, a decision that helped remove a key source of uncertainty for investors. The company continues to project mid-to-high single-digit net sales growth at constant currencies and an expansion of its core EBITDA margin by approximately 100 basis points.
The results also underscored the company's ongoing strategic shift toward higher-margin products. Biosimilars accounted for 34% of total Q2 net sales, an increase from 30% in the same period a year earlier, highlighting progress in its move toward more complex biological medicines.
Market and Index Catalysts
The stock's advance was supported by a modestly positive tone in global equity markets. More structurally, Sandoz has seen increased institutional interest following its selection for inclusion in Switzerland's benchmark Swiss Market Index (SMI), which will be effective in September 2026. This development is expected to create incremental demand for the stock from index-tracking funds.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.